Clinical Trial Update: Dual Vaccine Trial in Myeloproliferative Neoplasms [Phase 1, Phase 2]

View source ↗

Summary

A dual vaccine trial in myeloproliferative neoplasms completed Phase 1/2 testing for polycythemia vera and essential thrombocythemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Thrombocythemia
• Polycythemia Vera

Snippet

Sponsor: Inge Marie Svane | Conditions: Polycythemia Vera, Essential Thrombocythemia | Phase 1, Phase 2 | Status: COMPLETED